MeghanJude(Campo)MooradianMD

PubMed

• It Takes a Village! Navigating the Challenges and Opportunities in Immune-Related Adverse Event Management.
  Maysa Vilbert, Leyre Zubiri, Meghan J Mooradian, Kerry L Reynolds
  JCO Oncology Practice. 2024-12-19
• 2 citations
  Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes ...
  Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, Vineet K Raghu, Chia-Yun Wu
  Journal of Clinical Oncology. 2024-12-10
• Musculoskeletal ultrasound characteristics of checkpoint inhibitor-associated inflammatory arthritis.
  Mazen Nasrallah, Greg Challener, Sara Schoenfeld, Mark Matza, Donald Lawrence
  Seminars in Arthritis and Rheumatism. 2024-12-01

Journal Articles

• Differential Expression of PD-L1 and IDO1 in Association with the Immune Microenvironment in Resected Lung Adenocarcinomas  
  M Lisa Zhang, Justin F Gainor, Meghan J Mooradian, Nature
• Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer.  
  Meghan Campo, Hani Al-Halabi, Melin Khandekar, Alice T Shaw, Lecia V Sequist, Henning Willers, Oncologist, 6/27/2016
• Hemophagocytic Lymphohistiocytosis in Adults.  
  Meghan Campo, Nancy Berliner, Hematol. Oncol. Clin. North Am., 10/2015
• Safety and outcome of patients treated with a modified outpatient intraperitoneal regimen for epithelial ovarian, primary peritoneal or fallopian tube cancer  
  Chiara Battelli, Meghan Campo, Mary K Buss, Christopher S Awtrey, Panagiotis A Konstantinopoulos, Chemotherapy, 2013
• Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.  
  Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, Robert C Doebele, Edward Garon, David E Gerber, Sarah B Goldberg, Peter S Hammerman, Rebecca S Heist, Thomas H..., Journal of Thoracic Oncology, 1/2010
• Join now to see all

Lectures

• A phase II study of cryoablation (cryo) of an enlarging tumor in patients (pts) with advanced lung cancer or melanoma receiving post-progression immune checkpoint inhi... 
  2019 ASCO Annual Meeting - 6/1/2019